About LiquiLume Diagnostics
LiquiLume Diagnostics was a Healthcare company based in San Jose (United States) founded in 2010. An optofluidic-based platform for immunodiagnostic solutions. It operates on a B2B model. Its Indian entity Thar Commercial Finance Private Limited reported revenue of ₹55.98 Cr. The company is recorded as dissolved. Its focus areas include Medical Devices, Diagnostics and Immunodiagnostics. Similar companies include Guardant Health, Foundation Medicine and ArcherDX; 3 of its 3 listed similar companies have raised funding.
Company details
LiquiLume Diagnostics, founded in 2010 in San Jose, United States, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and immunodiagnostics. An optofluidic-based platform for immunodiagnostic solutions. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters San Jose, United States
- SectorsHealthcare
- Website liquilume.com
- Legal Name Thar Commercial Finance Private Limited
- Date of Incorporation 25 Jul, 2008
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹55.98 Cr
FY 2025 · +7% YoY
- Indian entity net profit₹5.93 Cr
FY 2025 · 11% margin
- Indian entity EBITDA₹48.21 Cr
FY 2025 · 86% margin
Associated legal entities of LiquiLume Diagnostics
LiquiLume Diagnostics operates through Thar Commercial Finance Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Thar Commercial Finance Private Limited CIN U65999MH2008PTC185082 | Active | 25 Jul 2008 | Mumbai, Maharashtra | ₹56.0 Cr | 4 | View details |
Board of directors of Thar Commercial Finance Private Limited (LiquiLume Diagnostics)
Thar Commercial Finance Private Limited is the primary company behind LiquiLume Diagnostics. The board of Thar Commercial Finance Private Limited currently have 3 directors; the longest-serving is Vivek Jayesh Thar, appointed in 2015. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivek Jayesh Thar DIN 06812365 | Director | 21 Feb 2015 | 11 yrs 8 mo | Thar Commercial Finance Private Limited |
| Chintan Hitendra Shah DIN 01376629 | Director | 21 Jan 2019 | 7 yrs 9 mo | Thar Commercial Finance Private Limited |
| Yatin Ajitrai Mankad DIN 00786683 | Director | 10 May 2021 | 5 yrs 6 mo | Thar Commercial Finance Private Limited |
Financials of LiquiLume Diagnostics
Figures of Thar Commercial Finance Private Limited, the primary company behind LiquiLume Diagnostics, for FY 2025. Revenue was ₹55.98 Cr (+7% year on year). Net profit was ₹5.93 Cr (11% margin). EBITDA was ₹48.21 Cr (86% margin). Revenue has grown at a compounded annual rate of +9% over three years and 0% over five years.
- ₹55.98 CrRevenue · FY 2025 · +7% YoY
- ₹5.93 CrNet profit · 11% margin
- ₹48.21 CrEBITDA · 86% margin
- ₹49.96 CrPaid-up capital
- +9%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Thar Commercial Finance Private Limited are on its company page.
Detailed financial statements for LiquiLume Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to LiquiLume Diagnostics
LiquiLume Diagnostics has 3 listed similar companies in our database, 3 of them funded. They include Guardant Health, Foundation Medicine and ArcherDX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. |
Detailed similar companies of LiquiLume Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as LiquiLume Diagnostics (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Liquilume Diagnostics
Complete news archive for LiquiLume Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LiquiLume Diagnostics
LiquiLume Diagnostics was founded in 2010.
LiquiLume Diagnostics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
The primary company behind LiquiLume Diagnostics, Thar Commercial Finance Private Limited, reported revenue of ₹55.98 Cr for FY 2025, up 7% year on year.
LiquiLume Diagnostics, founded in 2010 in San Jose, United States, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and immunodiagnostics. An optofluidic-based platform for immunodiagnostic solutions. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
LiquiLume Diagnostics's top competitors include Guardant Health, Foundation Medicine and ArcherDX.
LiquiLume Diagnostics operates through Thar Commercial Finance Private Limited.
The legal entities of LiquiLume Diagnostics currently have 4 directors, including Yatin Ajitrai Mankad, Vivek Jayesh Thar, Chintan Hitendra Shah and others.